HARUROPI Trademark

Trademark Overview

On Wednesday, July 25, 2018, a trademark application was filed for HARUROPI with the United States Patent and Trademark Office. The USPTO has given the HARUROPI trademark a serial number of 88052731. The federal status of this trademark filing is REGISTERED as of Tuesday, November 26, 2019. This trademark is owned by HISAMITSU PHARMACEUTICAL CO., INC.. The HARUROPI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of Parkinson's disease
haruropi

General Information

Serial Number88052731
Word MarkHARUROPI
Filing DateWednesday, July 25, 2018
Status700 - REGISTERED
Status DateTuesday, November 26, 2019
Registration Number5917801
Registration DateTuesday, November 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of Parkinson's disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 31, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHISAMITSU PHARMACEUTICAL CO., INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTosu-shi, Saga 841-0017
JP
Party NameHISAMITSU PHARMACEUTICAL CO., INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTosu-shi, Saga 841-0017
JP
Party NameHISAMITSU PHARMACEUTICAL CO., INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTosu-shi, Saga 841-0017
JP

Trademark Events

Event DateEvent Description
Monday, November 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 28, 2018NEW APPLICATION ENTERED
Tuesday, July 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 12, 2018ASSIGNED TO EXAMINER
Friday, November 23, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, November 28, 2018ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, December 12, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 1, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 15, 2019TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, February 19, 2019ASSIGNED TO PETITION STAFF
Friday, February 22, 2019PETITION TO DIRECTOR GRANTED
Friday, February 22, 2019JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, February 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 11, 2019NOTICE OF ALLOWANCE CANCELLED
Monday, March 11, 2019CASE RETURNED TO EXAMINATION
Friday, March 29, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, March 29, 2019SUSPENSION LETTER WRITTEN
Friday, March 29, 2019LETTER OF SUSPENSION E-MAILED
Friday, March 29, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 31, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 8, 2019ASSIGNED TO LIE
Thursday, August 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 21, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, November 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

haruropi pharmaceutical treatment preparations parkinson disease disorders nervous central system diseases